
    
      A decision was made to switch all patients on fingolimod 1.25 mg/day to fingolimod 0.5 mg/day
      in an amendment to the study protocol. The study became open-label with all patients
      receiving fingolimod 0.5 mg/day on 22 Feb 2010.

      The efficacy data for Months 0-6 in this study report is from the core study NCT00537082.
    
  